RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY : Impact Factor & More
eISSN: 2772-2708pISSN: 2772-2716
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Frequency | Semi-annual |
| General Details |
View less
Planning to publish in RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
FAQs on RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY
What is the publishing frequency of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY? 
What is the eISSN & pISSN for RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY?
Who is the publisher of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY?
